We are live on
!
Find out more
HP
HealthInvest Partners Portfolio holdings
AUM
$372M
1-Year Est. Return
59.89%
This Fund
S&P 500
This Quarter
Est. Return
+3.71%
1 Year Est. Return
+59.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$212M
AUM Growth
+$43.4M
(+26%)
Cap. Flow
+$33.5M
Cap. Flow
% of AUM
15.78%
Top 10 Holdings %
Top 10 Hldgs %
84.9%
Holding
17
New
3
Increased
6
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GNC
GNC Holdings, Inc.
GNC
|
+$27.7M |
| 2 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$16.8M |
| 3 |
FEIC
FEI COMPANY
FEIC
|
+$13.8M |
| 4 |
Anika Therapeutics
ANIK
|
+$12.9M |
| 5 |
Supernus Pharmaceuticals
SUPN
|
+$4.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$23.9M |
| 2 |
Charles River Laboratories
CRL
|
+$11.4M |
| 3 |
AIQ
Alliance Healthcare Services
AIQ
|
+$5.12M |
| 4 |
GTS
Triple-S Management Corporation
GTS
|
+$2.51M |
| 5 |
Gilead Sciences
GILD
|
+$2.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.79% |
| 2 | Industrials | 11.99% |
| 3 | Financials | 6.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LPNT
1
DELISTED
LifePoint Health, Inc.
LPNT
| $27.4M | 12.9% |
373,430
+57,000
| +18% | +$4.05M |
|
|
GNC
2
DELISTED
GNC Holdings, Inc.
GNC
| $25.5M | 11.99% |
+821,190
| New | +$27.7M |
|
|
3
Gilead Sciences
GILD
$162B
| $23.2M | 10.92% |
229,300
-20,000
| -8% | -$2.08M |
|
|
AMAG
4
DELISTED
AMAG Pharmaceuticals
AMAG
| $15.7M | 7.39% |
+520,000
| New | +$16.8M |
|
|
MGLN
5
DELISTED
Magellan Health Services, Inc.
MGLN
| $15.3M | 7.22% |
248,934
-11,508
| -4% | -$618K |
|
|
VAR
6
DELISTED
Varian Medical Systems, Inc.
VAR
| $14.9M | 7% |
209,830
-6,842
| -3% | -$473K |
|
7
Elevance Health
ELV
$81.5B
| $14.7M | 6.94% |
105,700
+1,500
| +1% | +$207K |
|
|
8
Charles River Laboratories
CRL
$11.2B
| $14.7M | 6.91% |
182,707
-157,613
| -46% | -$11.4M |
|
|
GTS
9
DELISTED
Triple-S Management Corporation
GTS
| $14.5M | 6.83% |
637,963
-114,610
| -15% | -$2.51M |
|
|
10
Anika Therapeutics
ANIK
$258M
| $14.5M | 6.8% |
378,745
+337,945
| +828% | +$12.9M |
|
|
FEIC
11
DELISTED
FEI COMPANY
FEIC
| $14.3M | 6.71% |
+178,763
| New | +$13.8M |
|
|
12
Supernus Pharmaceuticals
SUPN
$2.59B
| $14.1M | 6.65% |
1,051,277
+268,531
| +34% | +$4.15M |
|
|
SSRG
13
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $2.75M | 1.29% |
298,427
+120,846
| +68% | +$1.08M |
|
14
ImmuCell
ICCC
$101M
| $945K | 0.44% |
125,292
+16,542
| +15% | +$117K |
|
15
OraSure Technologies
OSUR
$279M
| – | – |
-276,603
| Closed | -$1.23M |
|
|
16
Pfizer
PFE
$143B
| – | – |
-802,094
| Closed | -$23.9M |
|
|
AIQ
17
DELISTED
Alliance Healthcare Services
AIQ
| – | – |
-524,538
| Closed | -$5.12M |
|
Similar funds
KP
AWA
TCM
SAAM
PAA
PC
BOCH
GIP
HealthInvest Partners's Q4 2015 Portfolio in Review
As of Q4 2015, HealthInvest Partners held 17 positions worth $212M, up 26% from $169M the previous quarter. Its ten largest holdings account for 85% of the portfolio.
HealthInvest Partners deployed $33.5M of net new capital in Q4 2015, opening 3 new positions and adding to 6 existing holdings. Its largest new stake was GNC Holdings, Inc.: 821,190 shares worth $25.5M.
By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 83% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Charles River Laboratories, an estimated $11.4M trimmed.
- HealthInvest Partners's largest Q4 2015 buy was GNC Holdings, Inc.: 821,190 shares worth $25.5M.
- HealthInvest Partners added most to Anika Therapeutics in Q4 2015, an estimated $12.9M increase.
- HealthInvest Partners's biggest Q4 2015 reduction was Charles River Laboratories, cutting an estimated $11.4M.
- HealthInvest Partners fully exited Pfizer in Q4 2015, selling an estimated $23.9M.
- HealthInvest Partners's ten largest holdings make up 85% of its $212M portfolio in Q4 2015.
- HealthInvest Partners opened 3 new positions and closed 3 in Q4 2015.
- HealthInvest Partners's portfolio value rose 26% quarter-over-quarter to $212M.
Based on HealthInvest Partners's 13F filing for Q4 2015, filed 11 Jan 2016.